Loading paragraph...
Loading chart_type...
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| ENHA | Enhanced | $2.88 | -$2.48 | -46.27% | 3.4M | $655M | $2.54$14.00 |
| CRBP | Corbus Pharmaceuticals | $8.44 | -$2.91 | -25.64% | 1.7M | $210M | $6.72$20.56 |
| PLYX | Polaryx Therapeutics | $2.71 | -$0.89 | -24.72% | 452.8K | $170M | $2.20$48.91 |
| OCTVV | Octave Intelligence Plc | $17.27 | -$4.48 | -20.60% | 231.6K | - | $17.25$30.00 |
| RYOJ | rYojbaba | $4.00 | -$1.00 | -20.00% | 578.4K | $58M | $1.56$11.43 |
| MTVA | MetaVia | $3.13 | -$0.72 | -18.70% | 2M | $20M | $0.97$19.03 |
| AMSS | Amass Brands | $3.52 | -$0.80 | -18.52% | 70.7K | $15M | $3.38$17.00 |
| RGTX | Tidal Trust II - Defiance Daily Target 2x Long Rgti ETF | $33.55 | -$7.23 | -17.73% | 4M | - | $11.80$499.12 |
| LFS | Leifras | $3.04 | -$0.51 | -14.37% | 27.5K | $93M | $1.58$12.49 |
| SUPX | SuperX Ai Technology | $10.50 | -$1.76 | -14.36% | 131.1K | $327M | $6.61$76.50 |
| GEMG | Themes ETF Trust - Leverage Shares 2x Long Gemi Daily ETF | $12.16 | -$1.92 | -13.61% | 9.2K | - | $9.18$354.60 |
| NXTC | NextCure | $6.81 | -$1.02 | -13.03% | 42.4K | $28M | $4.60$15.74 |
| RNAZ | TransCode Therapeutics | $5.43 | -$0.81 | -12.98% | 27.5K | $5.9M | $5.01$20.99 |
| MDAI | Spectral Ai | $2.36 | -$0.33 | -12.13% | 4.8M | $85M | $1.18$3.21 |
| GOVX | GeoVax Labs | $3.21 | -$0.43 | -11.81% | 69.7K | $13M | $0.96$34.75 |
| SDST | Stardust Power | $2.35 | -$0.30 | -11.32% | 42.1K | $28M | $1.43$7.67 |
| AZO | AutoZone | $3,022.26 | -$384.24 | -11.28% | 15.6K | $56B | $3,010.01$4,388.11 |
| BLIV | BeLive | $2.45 | -$0.05 | -2.00% | 35 | $27M | $1.85$5.13 |
Explore the biggest stock losers today along with up-to-date performance data, including the latest price, share price changes, trading volume, and more. We cover the top stock losers and decliners every day with market data, news, and analysis from our Foolish experts.